In triple-negative breast cancer, ANLN enhances tumor stemness via the TWIST1–BMP2 axis, coordinates EMT-related transcriptional programs, promotes extracellular matrix degradation, and consequently facilitates tumor initiation and progression (Maryam and Chin, 2021). The gene discussed is BMP2; the disease is triple-negative breast carcinoma.